Health Care
CRL — Charles River Laboratories
Status
scheduled
Consensus EPS
1.96
Consensus revenue
$0.99B
First close after
—
Snapshots (0)
No snapshots yet for this EC. Either T-5 hasn't fired or we're in the pre-launch bucket.
Past earnings · CRL
| Quarter ended | EPS est | EPS actual | Surprise |
|---|---|---|---|
| Dec 31 2025 | 2.35 | 2.39 | +1.91% |
| Sep 30 2025 | 2.34 | 2.43 | +3.86% |
| Jun 30 2025 | 2.55 | 3.12 | +22.45% |
| Mar 31 2025 | 2.07 | 2.34 | +12.78% |